A 36-base hairpin within lncRNA DRAIC, which is modulated by alternative splicing, interacts with the IKKα coiled-coil domain and inhibits NF-κB and tumor cell phenotypes
A tumor-suppressive long-noncoding RNA (lncRNA) DRAIC (downregulated RNAin cancers) inhibits NF-κB activity and physically interacts with IKKα, a kinase component of the IKK complex, in several cancer types. Here we explore the precise molecular mechanism involved in this interaction and suppression. Using SHAPE-MaP, we identified a 36-nucleotide hairpin (A + B) within DRAIC that is necessary and sufficient for its anti-oncogenic function. RNA immunoprecipitation (RIP) and Electrophoretic mobility shift assays (EMSA) confirmed that this hairpin physically interacts with the coiled coil domain of IKKα. A + B RNA has a high-binding affinity (KD ∼1-7 nM) to IKKα. The binding of A + B disrupts the dimerization of NEMO and IKKα coiled-coil domains, a critical step for IKK action. Consistent with this, A + B inhibits the phosphorylation of the NF-κB inhibitor IκBα and suppresses NF-κB activity. Publicly available tumor RNAseq data revealed that alternative splicing modulates the presence of this critical hairpin: The inclusion of exon 4a (encoding one side of the A + B hairpin) in lung tumors correlates with reduced NF-κB activity. By demonstrating that the A + B hairpin is both necessary and sufficient to inhibit IKK and oncogenic phenotypes, this study underscores the centrality of IKKα interaction and NF-κB inhibition in DRAIC-mediated cancer suppression and indicates that the activity of this lncRNA is regulated by alternative splicing. This study also reveals the first example of a short RNA disrupting coiled-coil dimerization, offering a new approach to disrupt such dimerization in cancer biology.
Authors
- Chase A. Weidmann (ORCID: https://orcid.org/0000-0002-2941-0500)
- Isaac K. Nardi (ORCID: https://orcid.org/0000-0003-3604-9917)
- Yuechuan Chen (ORCID: https://orcid.org/0000-0001-6856-1582)
- Anindya Dutta (ORCID: https://orcid.org/0000-0002-4319-0073)
- Kevin M. Weeks (ORCID: https://orcid.org/0000-0002-6748-9985)
- Divya Sahu (ORCID: https://orcid.org/0000-0003-1246-8412)
- Róża K. Przanowska (ORCID: https://orcid.org/0000-0003-1278-6242)
- Xiaoxiao Hao (ORCID: https://orcid.org/0000-0003-4404-5246)
- Mujawar Aaiyas
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Michigan (US)
- University of Alabama at Birmingham (US)
- Michigan Center for Translational Pathology (US)
- Clinilabs (United States) (US)
- University of Virginia (US)
- College of Business and Technology (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1016/j.jbc.2025.110172
- Citations
- 1
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.94